HDAC inhibitors and immunotherapy; a double edged sword?

Por Kroesen, Michiel, Gielen, Paul, Brok, Ingrid C., Armandari, Inna, Hoogerbrugge, Peter M., Adema, Gosse J.
Publicado em 2014

Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents

Por Kroesen, Michiel, Brok, Ingrid C., Reijnen, Daphne, van Hout-Kuijer, Maaike A., Zeelenberg, Ingrid S., Den Brok, Martijn H., Hoogerbrugge, Peter M., Adema, Gosse J.
Publicado no Cancer Immunol Immunother (2015)

Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma

Por Kroesen, Michiel, Büll, Christian, Gielen, Paul R., Brok, Ingrid C., Armandari, Inna, Wassink, Melissa, Looman, Maaike W. G., Boon, Louis, den Brok, Martijn H., Hoogerbrugge, Peter M., Adema, Gosse J.
Publicado no Oncoimmunology (2016)